[HTML][HTML] Associations between serum PFOA and PFOS levels and incident chronic kidney disease risk in patients with type 2 diabetes

Z Li, Y Zhang, F Wang, R Wang, S Zhang… - Ecotoxicology and …, 2022 - Elsevier
Chronic kidney disease (CKD) is a common comorbidity among patients with type 2
diabetes. Exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) …

Associations between serum PFOA and PFOS levels and incident chronic kidney disease risk in patients with type 2 diabetes.

Z Li, Y Zhang, F Wang, R Wang, S Zhang, Z Zhang, P Li… - 2022 - cabidigitallibrary.org
Chronic kidney disease (CKD) is a common comorbidity among patients with type 2
diabetes. Exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) …

Associations between serum PFOA and PFOS levels and incident chronic kidney disease risk in patients with type 2 diabetes

Z Li, Y Zhang, F Wang, R Wang… - Ecotoxicology and …, 2022 - ui.adsabs.harvard.edu
Chronic kidney disease (CKD) is a common comorbidity among patients with type 2
diabetes. Exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) …

Associations between serum PFOA and PFOS levels and incident chronic kidney disease risk in patients with type 2 diabetes.

Z Li, Y Zhang, F Wang, R Wang, S Zhang… - Ecotoxicology and …, 2021 - europepmc.org
Chronic kidney disease (CKD) is a common comorbidity among patients with type 2
diabetes. Exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) …

Associations between serum PFOA and PFOS levels and incident chronic kidney disease risk in patients with type 2 diabetes

Z Li, Y Zhang, F Wang, R Wang… - Ecotoxicology and …, 2022 - pubmed.ncbi.nlm.nih.gov
Chronic kidney disease (CKD) is a common comorbidity among patients with type 2
diabetes. Exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) …